Targeting the tyrosine kinase inhibitor-resistant mutant EGFR pathway in lung cancer without targeting EGFR?

Detalles Bibliográficos
Autores principales: De Greve, Jacques, Giron, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082287/
https://www.ncbi.nlm.nih.gov/pubmed/32206546
http://dx.doi.org/10.21037/tlcr.2020.01.05
_version_ 1783508316091056128
author De Greve, Jacques
Giron, Philippe
author_facet De Greve, Jacques
Giron, Philippe
author_sort De Greve, Jacques
collection PubMed
description
format Online
Article
Text
id pubmed-7082287
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-70822872020-03-23 Targeting the tyrosine kinase inhibitor-resistant mutant EGFR pathway in lung cancer without targeting EGFR? De Greve, Jacques Giron, Philippe Transl Lung Cancer Res Editorial AME Publishing Company 2020-02 /pmc/articles/PMC7082287/ /pubmed/32206546 http://dx.doi.org/10.21037/tlcr.2020.01.05 Text en 2020 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Editorial
De Greve, Jacques
Giron, Philippe
Targeting the tyrosine kinase inhibitor-resistant mutant EGFR pathway in lung cancer without targeting EGFR?
title Targeting the tyrosine kinase inhibitor-resistant mutant EGFR pathway in lung cancer without targeting EGFR?
title_full Targeting the tyrosine kinase inhibitor-resistant mutant EGFR pathway in lung cancer without targeting EGFR?
title_fullStr Targeting the tyrosine kinase inhibitor-resistant mutant EGFR pathway in lung cancer without targeting EGFR?
title_full_unstemmed Targeting the tyrosine kinase inhibitor-resistant mutant EGFR pathway in lung cancer without targeting EGFR?
title_short Targeting the tyrosine kinase inhibitor-resistant mutant EGFR pathway in lung cancer without targeting EGFR?
title_sort targeting the tyrosine kinase inhibitor-resistant mutant egfr pathway in lung cancer without targeting egfr?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082287/
https://www.ncbi.nlm.nih.gov/pubmed/32206546
http://dx.doi.org/10.21037/tlcr.2020.01.05
work_keys_str_mv AT degrevejacques targetingthetyrosinekinaseinhibitorresistantmutantegfrpathwayinlungcancerwithouttargetingegfr
AT gironphilippe targetingthetyrosinekinaseinhibitorresistantmutantegfrpathwayinlungcancerwithouttargetingegfr

Ejemplares similares